The decade since the Human Genome Project ended has witnessed a remarkable sequencing technology explosion that has permitted a multitude of questions about the genome to be asked and answered, at unprecedented speed and resolution. Here I present examples of how the resulting information has both enhanced our knowledge and expanded the impact of the genome on biomedical research. New sequencing technologies have also introduced exciting new areas of biological endeavour. The continuing upward trajectory of sequencing technology development is enabling clinical applications that are aimed at improving medical diagnosis and treatment.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Clinical Epigenetics Open Access 14 August 2023
BMC Bioinformatics Open Access 20 January 2023
Molecular Diagnosis & Therapy Open Access 02 September 2022
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Sanger, F., Nicklen, S. & Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 74, 5463–5467 (1977)
Mouse Genome Sequencing Consortium Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520–562 (2002)
Gibbs, R. A. et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428, 493–521 (2004)
International Chicken Genome Sequencing Consortium Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 432, 695–716 (2004)
Lindblad-Toh, K. et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438, 803–819 (2005)
The Chimpanzee Sequencing and Analysis Consortium Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437, 69–87 (2005)
Gibbs, R. A. et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 316, 222–234 (2007)
Warren, W. C. et al. Genome analysis of the platypus reveals unique signatures of evolution. Nature 453, 175–183 (2008)
Elsik, C. G. et al. The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science 324, 522–528 (2009)
Mardis, E. R. New strategies and emerging technologies for massively parallel sequencing: applications in medical research. Genome Med 1, 40 (2009)
Metzker, M. L. Sequencing technologies - the next generation. Nature Rev. Genet. 11, 31–46 (2010)
Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001)
International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature 431, 931–945 (2004)
The International HapMap Consortium The International HapMap Project. Nature 426, 789–796 (2003)
The International HapMap Consortium A haplotype map of the human genome. Nature 437, 1299–1320 (2005)
Frazer, K. A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007)
Altshuler, D. M. et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52–58 (2010)
Lander, E. S. Initial impact of the sequencing of the human genome. Nature doi:10.1038/nature09792 (this issue).
Harismendy, O. et al. Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level. Genome Biol. 11, R118 (2010)First demonstration that rare sequence variants could be identified using next-generation sequencing in well-phenotyped cases and controls, and that functional significance in the phenotype could be assigned to the suspect variants.
Kidd, J. M. et al. Mapping and sequencing of structural variation from eight human genomes. Nature 453, 56–64 (2008)
Tuzun, E. et al. Fine-scale structural variation of the human genome. Nature Genet. 37, 727–732 (2005)
Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444–454 (2006)
Conrad, D. F. et al. Origins and functional impact of copy number variation in the human genome. Nature 464, 704–712 (2010)
Korbel, J. O. et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 318, 420–426 (2007)
Chen, K. et al. BreakDancer: an algorithm for high resolution mapping of genomic structural variation. Nature Methods 6, 677–681 (2009)
Alkan, C. et al. Personalized copy number and segmental duplication maps using next-generation sequencing. Nature Genet. 41, 1061–1067 (2009)
Sudmant, P. H. et al. Diversity of human copy number variation and multicopy genes. Science 330, 641–646 (2010)Initial structural variation data analysis resulting from 1,000 Genomes Project data, demonstrating the yield of such information from a large-scale project using next-generation sequencing.
Durbin, R. M. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010)
Pao, W. et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl Acad. Sci. USA 101, 13306–13311 (2004)
Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006)
Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108–1113 (2007)
Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66–72 (2008)
Mardis, E. R. Cancer genomics identifies determinants of tumor biology. Genome Biol. 11, 211 (2010)
Mardis, E. R. The $1,000 genome, the $100,000 analysis? Genome Med 2, 84 (2010)
Birney, E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799–816 (2007)
Green, E. D., Guyer, M. S. & National Human Genome Research Institute Charting a course for genomic medicine from base pairs to bedside. Nature doi:10.1038/nature09764 (this issue).
Nelson, K. E. et al. A catalog of reference genomes from the human microbiome. Science 328, 994–999 (2010)
Loh, J. et al. Detection of novel sequences related to African Swine Fever virus in human serum and sewage. J. Virol. 83, 13019–13025 (2009)
Presti, R. M. et al. Quaranfil, Johnston Atoll, and Lake Chad viruses are novel members of the family Orthomyxoviridae. J. Virol. 83, 11599–11606 (2009)
Finkbeiner, S. R. et al. Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J. Virol. 83, 10836–10839 (2009)
Wheeler, D. A. et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 452, 872–876 (2008)
Lupski, J. R. et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 362, 1181–1191 (2010)Personal genome sequencing used to identify a rare allelic variant that causes Charcot-Marie-Tooth syndrome in the family of J. R. Lupski.
Roach, J. C. et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328, 636–639 (2010)
Jones, S. J. et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 11, R82 (2010)
Ng, S. B. et al. Exome sequencing identifies the cause of a mendelian disorder. Nature Genet. 42, 30–35 (2010)
Ng, S. B. et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nature Genet. 42, 790–793 (2010)One of the first demonstrations of using exome sequencing to identify a major causative mutation in Kabuki syndrome, using genomic DNA from a small number of unrelated affected individuals.
Gilissen, C. et al. Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome. Am. J. Hum. Genet. 87, 418–423 (2010)
Chin, C. S. et al. The origin of the Haitian cholera outbreak strain. N. Engl. J. Med. 364, 33–42 (2011)
I thank R. Wilson, D. Dooling and G. Weinstock for critical reading of the manuscript. J. McMichael was integral to the creation of Fig. 1.
I serve on the Scientific Advisory Board of Pacific Biosciences, Inc., and as part of my compensation for this service, I have stock options that have been granted to me. I am a former member of the Board of Directors of Applied Biosystems, which merged with Life Technologies in 2009. As part of my retirement from the Board membership, I received stock and stock options.
About this article
Cite this article
Mardis, E. A decade’s perspective on DNA sequencing technology. Nature 470, 198–203 (2011). https://doi.org/10.1038/nature09796
This article is cited by
Clinical Epigenetics (2023)
BMC Bioinformatics (2023)
InFo Neurologie + Psychiatrie (2022)
Molecular Diagnosis & Therapy (2022)